China: Initiative for General Cosmetics Filing and Inspection of China

ARQon
May 17, 2023
2 min read

Updated: May 30, 2023

On 18th January 2023, the National Medical Products Administration (NMPA) announced the initiatives for general cosmetics filing and inspection in China. The announcement was enforced immediately upon the release date.

Currently, NMPA allows the general cosmetic manufacturer to run self-testing and inspection on the products. This initiative will maximize the general cosmetic filing in China. The reports from the self-testing can be used in the filing application.

Cosmetic manufacturers that choose to run self-testing and inspection on the products, manufacturers must provide the information of inspection personnel, equipment list, facilities, and site environment involved during the testing and inspection. The filer also must submit a statement to show the inspection capabilities based on the Specifications for Cosmetics Registration and Filing and Inspection Work. All this inspection information and self-testing report must be submitted together during the filing. Below are a few of the specifications for self-testing manufacturers or filers should obey:

Registered and certified cosmetic production license
Systematic inspection and laboratory management system
Complete inspection equipment and facilities suitable for product requirements
Efficient quality inspection teams and strict inspection process
Strong sample inspection management
Responsible for the authenticity of sample and inspection items

However, if cosmetic manufacturers plan to hire trusted inspection manufacturers or cosmetic filers, the inspection report still can be submitted based on the cosmetics’ technical requirements specifications during product filing if the production license is included in the daily supervision of the provincial Medical Products Administration (MPA), the inspection method obeys the quality control measures and it may confirm the products’ safety. However, any products to be used by infants and children, products with new raw material usage and products that might have effects such as acne removal, anti-dandruff or deodorization, may not be inspected by the trusted inspection manufacturers.

Next, Province Medical Products Administration (MPA) is responsible for receiving the general cosmetic filing applications and verifying all the applications fulfilling the China General Cosmetics Filing and Inspection Measures. Hence, MPA must strengthen the supervision measures, strictly supervise self-testing filers or trusted manufacturers, monitor the inspection establishment and laboratory system and monitor manufacturers’ capabilities and records.

Source: NMPA